Searching journal content for articles similar to Cooper 25 (10): 1423.

Displaying results 1-10 of 158
For checked items
  1. ...with rare diseases often undergo a frustrating and expensive diagnostic odyssey. Clinical geneticists who analyze exome or sequencing data from rare disease patients often encounter a list of variants of uncertain significance (VUS) in known disease-causing genes or rare variants in genes of uncertain...
  2. ...) pathogenic, (VUS) variant of uncertain significance.RE identification with short-read sequencingThe primary purpose of this trial was to compare the performance of SR-GS and LR-AS for the identification of pathogenic RE. At the time of trial initiation (2022), there were 67 known pathogenic REs, 17 directly...
  3. ..., SynMall identifies two recently reported sSNVs linked to cardiovascular disease.In the second case, we use “breast” as the keyword (Supplemental Fig. S8A). Following the same procedure as in the first case, we focus on the ClinVar VUS 13:g.32357903A > T with the highest SynScore (Supplemental Fig. S8B...
  4. ...editing by recruiting endogenous ADARs with antisense oligonucleotides. Nat Biotechnol 37: 133–138. doi:10 .1038/s41587-019-0013-6 Meyers BC, Vu TH, Tej SS, Ghazal H, Matvienko M, Agrawal V, Ning J, Haudenschild CD. 2004. Analysis of the transcriptional complexity of Arabidopsis thaliana by massively...
  5. ..., particularly in the presence 49 of large numbers of unannotated sequences (Vu et al. 2023). 50 A primary challenge in protein function prediction is the imbalance in annotation 51 specificity. This issue arises from the hierarchical structure of the Gene Ontology (GO), 52 a Directed Acyclic Graph (DAG...
    ACCEPTED MANUSCRIPT
  6. .... Classification of BRCA2 variants of uncertain significance (VUS) using an 667 ACMG/AMP model incorporating a homology-directed repair (HDR) functional assay. Clinical 668 Cancer Research 28: 3742-3751. 669 28 Hu Z, Shi Z, Guo X, Jiang B, Wang G, Luo D, Chen Y, Zhu Y-S. 2018. Ligase IV inhibitor SCR7 enhances 670...
    ACCEPTED MANUSCRIPT
  7. ...or likely pathogenic variants (P/LP) nor variants of uncertain significance (VUS) identified (Bowling et al. 2017, 2022; East et al. 2021). Most of our cohort consisted of children (89% were <18 years of age at the time of enrollment) with an NDD (70%), multiple congenital anomalies (MCA, 22...
  8. ..., a few likely pathogenic deep intronic variants were revealed recently, when Ambry Genetics undertook short-read RNA-seq analysis of thousands of variants that they had classified as VUS, in order to identify those altering splicing (Horton et al. 2024). Nearly all the re-evaluated variants were...
  9. ...-causing variants (variants of unknown significance [VUS]) in the complete study cohortDisease-causing variants identified in rare neurological and neuromuscular diseases, and epilepsiesAfter prioritizing and clinically interpreting genetic variants in the 93 families from the “unsolved” subcohort, we established...
  10. ...clinical significance in ClinVar (n = 64) including pathogenic/likely pathogenic (P/LP), conflicting classifications of pathogenicity, uncertain significance (VUS), and benign/likely benign (B/LB). Nonsense and missense variants were excluded. (B) Estimation of likelihood ratio for pathogenicity for each...
For checked items

Preprint Server